A multiple-ascending-dose study to evaluate the efficacy, safety, and pharmacokinetics (PK) of MEDI0382 in overweight and obese participants with Type 2 Diabetes Mellitus

Trial Identifier: D5670C00002
Sponsor: MedImmune, LLC
NCTID:: NCT02548585
Start Date: December 2015
Primary Completion Date: February 2017
Study Completion Date: February 2017
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 10117
Germany Erfurt, Germany, 99084
Germany Heidelberg, Germany, 69120
Germany Kiel, Germany, 24105
Germany Leipzig, Germany, 04103
Germany Lübeck, Germany, 23538
Germany Magdeburg, Germany, 39120
Germany Mainz, Germany, 55116
Germany Mannheim, Germany, 68167
Germany München, Germany, 81241
Germany Munster, Germany, 48145
Germany Neuss, Germany, 41460
Germany Neu-Ulm, Germany, 89231
Germany Schwerin, Germany, 19053